Fewer Functional Deficits and Reduced Cell Death after Ranibizumab Treatment in a Retinal Ischemia Model.

Int J Mol Sci · 2018 · PMC6032266 · PMID 29857531

Europe PMC DOI

hedged sentence

0.2700

closest p · 5.4× alpha

0.2700

boldest claim

The sentences

a slight trendp = 0.27not close (p > 0.1)

There was no difference between ischemic retinae and those treated with the VEGF inhibitors (beva: p = 0.75; rani: p = 0.27), although a slight trend to fewer Bax + cells was observed in the ranibizumab-treated group in relation to the ischemic group ( p = 0.27).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.